Thought Leadership
Thought leadership content establishes healthcare leaders and their organizations as trusted experts, inspiring target audiences to take next steps based on evidence, not hard-sell tactics. Providing intelligent insight and useful information to readers paves the way for building awareness, starting a conversation, solving problems, and answering questions.
REFERRING PHYSICIAN AUDIENCE
Memorial Sloan Kettering Cancer Center: Clinical Updates & Insights
- Groundbreaking Advances for Patients with Muscle-Invasive Bladder Cancer and More to Come
- ESMO 2025 Research Roundup: MSK Presents Exciting Advances in Medical Oncology Research
- Tailoring Adjuvant Therapy for Younger Patients with Low-Risk Breast Cancer
- Proton Beam Reduces Acute Toxicities Compared to IMRT for Head and Neck Cancer Patients Who Receive Unilateral Radiation
- MSK Kids: Recent Research Advances for High-Risk Neuroblastoma
- Select Patients With Early-Stage Breast Cancer May Safely Skip Post-Mastectomy Nodal Irradiation
- MSK Head and Neck Cancer: Thyroid Cancer Research Update
- Three Decades in the Making: Advancing Rectal MRI at MSK
- Neoadjuvant and Adjuvant Pembrolizumab with Standard-of-Care Significantly Improves Event-Free Survival in Head and Neck Cancer
- ASCO 2025 Research Roundup: MSK Presents Practice-Changing Advances in Cancer Research
- ASCO 2025 News: Groundbreaking Survival Advances for Patients with ER+/HER2- Advanced Breast Cancer
- Brachytherapy for Brain Metastases
INNOVATOR AUDIENCE
Memorial Sloan Kettering Cancer Center: Office of Entrepreneurship & Commercialization
- MSK to Deploy Triomics’ AI Platform to Improve Clinical Trial Matching and Screening
- MSK EBP Consulting Collaborates with HealthLinx to Bring Evidence-Based Practice to More Hospitals Across the U.S.
- Dr. Nai-Kong Cheung honored with 2025 Lifetime Achievement Award from the Advances in Neuroblastoma Research Association
- Dr. Danny Khalil wins Harrington Discovery Institute 2025 Scholar-Innovator Award
- MSK Expands Collaboration with Curadev Through MSK Therapeutics Accelerator Program
- MSK iHub Challenge 2025 Cohort Now Open for Applications
- MSK Partners with PathPresenter to Integrate New AI Module for Oncology Research
- MSK’s WOUND-Q™ Questionnaire is FDA-Qualified as a Medical Device Development Tool
- MSK Presents Significant Data Study Findings to FDA
- MSK Joins Global Clinical Research Innovation Task Force
RESEARCHER AUDIENCE
Worldwide Clinical Trials
Targeted Therapies in Oncology
Precision Oncology - Clinical Leader
PATIENT AUDIENCE
Bristol-Myers Squibb - Life & Science Magazine
